Sage Journals: Discover world-class research

Retricted access

Research article

First published 2013-4

Clinical relevance of serum natalizumab concentration and anti-natalizumab antibodies in multiple sclerosis

Anke Vennegoor, Theo Rispens, Eva MM Strijbis [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2005-10

Relapse rates and enhancing lesions in a phase II trial of natalizumab in multiple sclerosis

Paul O'Connor, David Miller, Katherine Riester [...]

Multiple Sclerosis Journal

Retricted access

Other

First published 2009-11

Clinical efficacy and benefit of natalizumab

Patricia K Coyle, Douglas R Jeffery

Multiple Sclerosis Journal

Open access

Research article

First published 2018-5

The majority of natalizumab-treated MS patients have high natalizumab concentrations at time of re-dosing

Zoé LE van Kempen, Cyra E Leurs, Birgit I Witte [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2011-8

Pregnancy and natalizumab: results of an observational study in 35 accidental pregnancies during natalizumab treatment

Kerstin Hellwig, Aiden Haghikia, Ralf Gold

Multiple Sclerosis Journal

Free access

Review article

First published 2009-03

Review: Natalizumab in the treatment of multiple sclerosis

Özgür Yaldizli, Norman Putzki

Therapeutic Advances in Neurological Disorders

Retricted access

Research article

First published 2005-11

Natalizumab for the Treatment of Multiple Sclerosis and Crohn's Disease

Kendra A Keeley, Michael P Rivey, Douglas R Allington

Annals of Pharmacotherapy

Open access

Review article

First published 2010

Pharmacotherapy Options for Multiple Sclerosis: Focus on Natalizumab

Martin Stangel, Bernd C. Kieseier

Clinical Medicine Insights: Therapeutics

Retricted access

Other

First published 2008-06

Paradoxically aggressive multiple sclerosis in the face of natalizumab therapy

JR Berger

Multiple Sclerosis Journal

Retricted access

Other

First published 2009-12

Melanoma in multiple sclerosis treated with natalizumab: causal association or coincidence?

Roberto Bergamaschi, Cristina Montomoli

Multiple Sclerosis Journal

Search results